tirzepatide and skin rash Mounjaro® Skin Side Effects &

Zepbound 2.5 mg weekly 4 weeks 5 mg weekly 2.5 mg steps 5 mg, 10 mg or 15 mg 15 mg weekly Mounjaro 2.5 mg weekly 4 weeks 5 mg weekly 2.5 mg steps Additional glycemic control 15 mg weekly Important: Zepbound is used for eligible weight-management patients, while Mounjaro is used for adults with type 2 diabetes

By combining telehealth technology, clinical data, and behavioral science, Brello offers highly personalized treatment plans tailored to each patient's unique health profile

What triggers symptoms at a fast escalation rate may produce no symptoms at all when the same total dose is reached more slowly

This innovative treatment has shown promising results in addressing weight management, making it a potential game-changer in the field of obesity and metabolic health

"FDA approves Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity" (Press release)